Article
A Variant Allele in Varicella-Zoster Virus Glycoprotein B Selected during Production of the Varicella Vaccine Contributes to Its Attenuation.
mBio - 30 Aug 2022
Sadaoka Tomohiko, Depledge Daniel P, Rajbhandari Labchan, Breuer Judith, Venkatesan Arun, Cohen Jeffrey I
Abstract excerpt
Attenuation of the live varicella Oka vaccine (vOka) has been attributed to mutations in the genome acquired during cell culture passage of pOka (parent strain); however, the precise mechanisms of attenuation remain unknown. Comparative sequence analyses of several vaccine batches showed that over 100 single-nucleotide polymorphisms (SNPs) are conserved across all vaccine batches; 6 SNPs are nearly fixed,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
